Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A systemic inflammation response index (SIRI) correlates with survival and predicts oncological outcome for mFOLFIRINOX therapy in metastatic pancreatic cancer.
Pacheco-Barcia V, Mondéjar Solís R, France T, Asselah J, Donnay O, Zogopoulos G, Bouganim N, Guo K, Rogado J, Martin E, Alcindor T, Colomer R. Pacheco-Barcia V, et al. Among authors: mondejar solis r. Pancreatology. 2020 Mar;20(2):254-264. doi: 10.1016/j.pan.2019.12.010. Epub 2019 Dec 14. Pancreatology. 2020. PMID: 31866391
Bevacizumab in Combination with Capecitabine plus Irinotecan as First-Line Therapy in Metastatic Colorectal Cancer: A Pooled Analysis of 2 Phase II Trials.
García Alfonso P, Muñoz Martin A, Alvarez Suarez S, Blanco Codeidido M, Mondejar Solis R, Tapia Rico G, López Martín P, Martin M. García Alfonso P, et al. Among authors: mondejar solis r. Onkologie. 2013;36(6):363-7. doi: 10.1159/000351240. Epub 2013 May 21. Onkologie. 2013. PMID: 23774151 Clinical Trial.
Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma: the BIBABRAX study.
Feliu J, Jorge Fernández M, Macarulla T, Massuti B, Albero A, González González JF, Quintero-Aldana G, Delgado-Mingorance JI, Fernández Montes A, García Piernavieja C, Valladares-Ayerbes M, López Muñoz AM, Mondéjar Solís R, Vicente P, Casado Gonzalez E, González Cebrián I, López-Vivanco G. Feliu J, et al. Among authors: mondejar solis r. Cancer Chemother Pharmacol. 2021 Apr;87(4):543-553. doi: 10.1007/s00280-020-04214-w. Epub 2021 Jan 15. Cancer Chemother Pharmacol. 2021. PMID: 33452559 Clinical Trial.
[(18)F-FDG PET/CT in the evaluation of patients suspected of paraneoplastic neurological syndrome].
García Vicente AM, Vega Caicedo CH, Mondéjar Solís R, de Ayala Fernández JÁ, Garrido Robles JA, Pena Pardo FJ, Muñoz Pasadas M, Del Saz Saucedo P, Jiménez Londoño GA, León Martín A, Soriano Castrejón Á. García Vicente AM, et al. Among authors: mondejar solis r. Rev Esp Med Nucl Imagen Mol. 2015 Jul-Aug;34(4):236-43. doi: 10.1016/j.remn.2015.02.006. Epub 2015 Apr 10. Rev Esp Med Nucl Imagen Mol. 2015. PMID: 25864422 Spanish.